Rights and permissions
About this article
Cite this article
Spanish study favours use of abciximab in high-risk PTCA. Pharmacoecon. Outcomes News 78, 5 (1996). https://doi.org/10.1007/BF03270247
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03270247